Prothrombin G20210A Mutation

The Prothrombin G20210A Mutation is a genetic change that affects the blood's ability to clot properly. It involves a mutation in the gene responsible for producing prothrombin, a protein essential for blood clot formation. This mutation increases the risk of developing abnormal blood clots, especially in veins, which can lead to conditions like deep vein thrombosis or pulmonary embolism. The mutation primarily impacts the circulatory system by making blood more prone to clotting. People with this mutation may not have symptoms until a clot forms, which can cause pain, swelling, or more serious complications. Understanding this mutation helps explain why some individuals have a higher tendency for blood clots.

Prothrombin G20210A Mutation is a genetic thrombophilia caused by a single nucleotide substitution (G to A) at position 20210 in the 3' untranslated region of the F2 gene encoding prothrombin. This mutation leads to elevated plasma prothrombin levels, resulting in a hypercoagulable state and increased risk of venous thromboembolism (VTE). It is inherited in an autosomal dominant pattern with variable penetrance. Clinically, it is a significant risk factor for deep vein thrombosis (DVT) and pulmonary embolism (PE), especially when combined with other acquired or inherited thrombophilias. The mutation does not typically affect arterial thrombosis risk. Diagnosis is important for risk stratification and management of thrombotic events.